Ulobetasol
From Wikipedia, the free encyclopedia
Ulobetasol
|
|
Systematic (IUPAC) name | |
(6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)- 6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl- 6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | |
Identifiers | |
CAS number | |
ATC code | D07 |
PubChem | |
Chemical data | |
Formula | C22H27ClF2O4 |
Mol. mass | 428.897 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Ulobetasol (or halobetasol) is a corticosteroid.